Analysis of ochratoxin a blood levels in bladder cancer cases and healthy persons from Pakistan

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 75, Issue 19-20, 2012, Pages 1176-1184

  Aslam, Muhammad ^a   Abidul Hassan Rivzi, S ^b   Beg, Anwer Ejaz ^a   Blaszkewicz, Meinolf ^c   Golka, Klaus ^c   Degen, Gisela H ^c  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b SINDH INSTITUTE OF UROLOGY AND TRANSPLANTATION   (Pakistan)

^c LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OCHRATOXIN; CARCINOGEN;

ADULT; AFRICA; AGED; ASIA; BLADDER CANCER; BLOOD ANALYSIS; BLOOD LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; FLUORESCENCE; GENOTOXICITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PAKISTAN; PRIORITY JOURNAL; TOXIN ANALYSIS; WESTERN HEMISPHERE; ARTICLE; BLADDER TUMOR; BLOOD; CHEMICALLY INDUCED DISORDER; CITY; COHORT ANALYSIS; DEVELOPING COUNTRY; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; CARCINOGENS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITIES; COHORT STUDIES; DEVELOPING COUNTRIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OCHRATOXINS; PAKISTAN; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 84866725458     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287394.2012.707602     Document Type: Conference Paper

References (39)

1. Abid, S., Hassen, W., Achour, A., Skhiri, H., Maaroufi, K., Ellouz, F., Creppy, E., and Bacha, H. 2003. Ochratoxin A and human chronic interstitial nephropathy in Tunisia: Is the situation endemic? Hum. Exp. Toxicol. 22: 77-84.
2. Aslam, M., Beg, A. E., Blaszkewicz, M., Degen, G. H., and Golka, K. 2005. Ochratoxin A blood concentration in healthy subjects and bladder cancer cases from Pakistan. Mycotoxin Res. 21: 164-67.
3. Bamias, G., and Boletis, J. 2008. Balkan nephropathy: Evolution of our knowledge. Am. J. Kidney Dis. 52: 606-16.
4. Benford, D., Boyle, C., Dekant, W., Fuchs, R., Gaylor, D. W., Hard G., McGregor, D. B, Pitt, J. I., Plestina, R., Shephard, G., Solfrizzo, M., Verger, P. J. P., and Walker, R. 2001. Ochratoxin A. In Safety evaluations of certain mycotoxins in food,WHO Food Additives Series 47, FAO Food and Nutrition Paper 74, IPCS International Programme on Chemical Safety, WHO, Geneva, pp. 281-387 + Appendix A, pp. 388-415.
5. Blaszkewicz, M., and Baumhoer, G. 2010. Ochratoxin A. In Analytische Methoden zur Prüfung gesundheitsschädlicher Arbeitsstoffe. Analysen in biologischem Material, ed. A. Hartwid, Bd. 2. 19. Lfg. (S. D1-D3 (O) and S. 1-18 (O)). Weinheim, Germany: Wiley-VCH.
6. Breitholtz-Emanuelsson, A., Minervini, F., Hult, K., and Visconti, A. 1994. Ochratoxin A in human serum samples collected in southern Italy from healthy individuals and individuals suffering from different kidney disorders. Nat. Toxins 2: 366-70.
7. Castegnaro, M., Canadas, D., Vrabcheva, T., Petkova-Bocharova, T., Chernozemsky, I. N., and Pfohl-Leszkowicz, A. 2006. Balkan endemic nephropathy: Role of ochratoxins A through biomarkers. Mol. Nutr. Food Res. 50: 519-29.
8. Clark, H. A., and Snedeker, S. M. 2006. Ochratoxin A: Its cancer risk and potential for exposure. J. Toxicol. Environ. Health B 9: 265-96.
9. Coronel, M. B., Sanchis, V., Ramos, A. J., and Marin, S. 2010. Review. Ochratoxin A: Presence in human plasma and intake estimation. Food Sci. Technol. Int. 16: 5-18.
10. Degen, G. H. 2011. Tools for investigating workplace related risks from mycotoxin exposure. World Mycotoxin J. 4: 315-27.
11. Degen, G. H., Blaszkewicz, M., Lektarau, Y., and Grüner, C. 2003. Ochratoxin A Analysen im Blut von Arbeitnehmern in der Abfallwirtschaft. Mycotoxin Res. 19: 3-7.
12. Degen, G. H., Lebrun, S., Lektarau, Y., and FöllmannW. 2005. Modulation of ochratoxin A induced DNA damage in urothelial cell cultures. Mycotoxin Res. 21: 57-60.
13. Dörrenhaus, A., Flieger A., Degen, G. H., Schulze H., Albrecht M., and Föllmann W. 2000. Induction of unscheduled DNA synthesis in primary human urothelial cells by the mycotoxin ochratoxin A. Toxicol. Sci. 53: 271-77.
14. European Commission. 2006. Commission Regulation (EC) No. 1881/2006 of 19 December 2006 setting maximum levels for certain contaminants in foodstuffs. Offic. J. Eur. Union L 364: 5-24.
15. European Food Safety Authority. 2006. Opinion of the scientific panel on contaminants in the food chain on request from the commission related to ochratoxin A in food. EFSA J. 365:1-56. Available at: http://www.efsa.europa.eu/ EFSA/efsa-locale-1178620753812-1178620762138.htm (accessed 15 June 2011).
16. Föllmann, W., Behm, C., and Degen, G. H. 2007. Induction of micronuclei by ochratoxin A is a sensitive parameter of its genotoxicity in cultured cells. Mycotoxin Res. 23: 101-9.
17. Grajewski, J., Jarzemski, P., Twaruzek, M., Kuzminska, K., and Trepala, M. 2007. The level of ochratoxin A in patients after nephrectomy. Mycotoxin Res. 23:22-26.
18. Grosso, F., Said, S., Mabrouk, I., Fremy, J. M., Castegnaro, M., Jemmali, M., and Dragacci, S. 2003. New data on the occurrence of ochratoxin A in human sera from patients affected or not by renal diseases in Tunisia. Food Chem. Toxicol. 41: 1133-40.
19. Hmaissia-Khlifa, K., Ghali, R., Mezigh, C., Aouni, Z., Ghorbel, H., Harrzallah, K., Machgoul, S., and Hedhili, A. 2008. Serum levels of ochratoxin A in healthy subjects and in nephropathic patients in Tunisia. Ann. Biol. Clin. (Paris) 66: 631-36.
20. Hmaissia-Khlifa, K., Ghali, R., Mazigh, C., Aouni, Z., Machgoul, S., and Hedhili, A. 2010. Ochratoxin A levels in human serum and foods from nephropathy patients in Tunisia: Where are we now? Exp. Toxicol. Pathol. 62: 539-42.
21. Hornung, R. W., and Reed, L. D. 1990. Estimation of average concentration in the presence of nondetectable values. Appl. Occup. Environ. Hyg. 5: 46-51.
22. Hult, K., Plestina, R., Habazin-Novak, V., Radic, B., and Ceovic S. 1982. Ochratoxin A in human blood and Balkan endemic nephropathy. Arch. Toxicol. 51: 313-21.
23. Kuiper-Goodman, T., Hilts, C., Billiard, S. M., Kiparissis, Y., Richard, I. D. K., and Hayward, S. 2010. Health risk assessment of ochratoxin A for all age-sex strata in a market economy. Food Addit. Contam. A Chem. Anal. Control. Expos. Risk Assess. 27: 212-40.
24. Märtlbauer, E., Usleber, E., Dietrich, R., and Schneider, E. 2009. Ochratoxin A in human blood serum-Retrospective long-term data. Mycotoxin Res. 25: 175-86.
25. Malir, F., Brndiar, M., Roubar, T., Severa, J., Fixa, P., Kacerovsky, J., Zahradnik, J., Osterreicher, J., Knizek, J., and Cerna, M. 2001. A study of the accumulation of ochratoxin A (OTA) in patients with chronic renal insufficiency (CHRI) in the Czech Republic. Mycotoxin Res. 17: 39-44.
26. Mally, A., Hard, G. C., and Dekant W. 2007. Ochratoxin A as a potential etiologic factor in endemic nephropathy: Lessons from toxicity studies in rats. Food Chem. Toxicol. 45: 2254-60.
27. Özçelik, N., Kosar, A., and Soysal, D. 2001. Ochratoxin A in human serum samples collected in Isparta-Turkey from healthy individuals and individuals suffering from different urinary disorders. Toxicol. Lett. 121: 9-13.
28. Peraica, M., Domijan, A. M., Miletic-Medved, M., and Fuchs, R. 2008. The involvement of mycotoxins in the development of endemic nephropathy. Wien. Klin. Wochenschr. 120: 402-407.
29. Petkova-Bocharova, T., Castegnaro, M., Pfohl-Leszkowicz, A., Garren, L., Grosso, F, Nikolov, I., Vrabcheva, T., Dragacci, S., and Chernozemsky, I. N. 2003. Analysis of ochratoxin A in serum and urine of inhabitants from an area with Balkan endemic nephropathy: One months follow up study. Facta Universitatis Ser.MedBiol. 10(2): 62-68.
30. Pfohl-Leszkowicz, A., Petkova-Bocharova, T., Chernozemsky, I. N., and Castegnaro, M. 2002. Balkan endemic nephropathy and associated urinary tract tumours: A review on aetiological causes and the potential role of mycotoxins. Food Addit. Contam. 19: 282-302.
31. Radic, B., Fuchs, R., Peraica, M., and Lucic, A. 1997. Ochratoxin A in human sera in the area with endemic nephropathy in Croatia. Toxicol. Lett. 91: 105-9. RASFF database 2011. http://ec.europa.eu/food/food/rapidalert/rasff- portal-database-en.htm (Accessed 15 June 2011)
32. Rosner, H., Rohrmann, B., and Peiker, G. 2000. Ochratoxin A in human serum. Arch Lebensmittelhygiene 51: 104-7.
33. Sahar, N., Ahmed, M., Parveen, Z., Ilyas, A., and Bhutto, A. 2009. Screening of mycotoxins in wheat, fruits and vegetables grown in Sindh, Pakistan. Pak. J. Bot. 41: 337-41.
34. SCOOP. 2002. Reports on tasks for scientific cooperation: assessment of dietary intake of ochratoxin A by the population of EU Member States. Directorate-General Health and Consumer Protection. http://ec.europa. eu/food/fs/scoop/3.2.7-en.pdf (accessed 15 June 2011)
35. Scott, P. M. 2005. Biomarkers of human exposure to ochratoxin A. Food Addit. Contam. 22 (suppl. 1): 99-107.
36. Shah, H. U., Simpson, T. J., Alam, S., Khattak, K. F., and Perveen, S. 2010. Mould incidence and mycotoxin contamination in maize kernels from Swat Valley, North West Frontier Province of Pakistan. Food Chem. Toxicol. 48: 1111-16.
37. Shamsuddin, Z. A., Khan, M. A., and Ahmed, A. 2006. Natural occurrence of ochratoxin 'A' in raisins in Pakistan. Pak. J. Sci. Ind. Res. 49: 43-47.
38. Stefanovic, V., and Radovanovic, Z. 2008. Balkan endemic nephropathy and associated urothelial cancer. Nat. Clin. Pract. Urol. 5: 105-12.
39. Wafa, E. W., Yahya, R. S., Sobh, M. A., Eraky, I., El-Baz, M., El-Gayar, H. A. M., Betbeder, A. M., and Creppy, E. E. 1998. Human ochratoxicosis and nephropathy in Egypt: A preliminary study. Human Exp. Toxicol. 17: 124-29.